PARK2 Co-Regulated (PACRG) Peptide
-
- Target See all PACRG products
- PACRG (PARK2 Co-Regulated (PACRG))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- GAIMARCNLD HLGSSDPPTS ASQVAEIIVN SGDGIDYSQQ KRENIGDLIQ
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of PACRG antibody,
Alternative Names: PACRG control peptide, PACRG antibody Blocking Peptide, Anti-PACRG Blocking Peptide, Park2 Co-Regulated Blocking Peptide, FLJ32724 Blocking Peptide, GLUP Blocking Peptide, HAK005771 Blocking Peptide, PARK2CRG Blocking Peptide, RP3-495O10.2 Blocking Peptide - Purification
- Purified
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- PACRG (PARK2 Co-Regulated (PACRG))
- Synonyms
- PACRG Peptide, GLUP Peptide, HAK005771 Peptide, PARK2CRG Peptide, RP3-495O10.2 Peptide, zgc:101786 Peptide, RGD1561027 Peptide, 1700008H23Rik Peptide, parkin coregulated Peptide, PARK2 co-regulated Peptide, PARK2 coregulated Peptide, PACRG Peptide, pacrg Peptide, Pacrg Peptide
- Background
- PACRG is a protein that is conserved across metazoans. In vertebrates, this gene is linked in a head-to-head arrangement with the adjacent parkin gene, which is associated with autosomal recessive juvenile Parkinson's disease. These genes are co-regulated in various tissues and they share a bi-directional promoter. Both genes are associated with susceptibility to leprosy.
- Molecular Weight
- 33 kDa
-